Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

By A. Kandiel, A. Fraser, B. Korelitz, C. Brensinger, James D Lewis. Gut, 2005

816 citations recorded by the source corpus.

Subfields: Epidemiology, Genetics, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/ade90ffcd878ed8e4d7578781d6db07f899c4775

Citations in the corpus

• Guidelines for the management of inflammatory bowel disease in adults (2011, neutral): “whereas a second suggested a fourfold increased risk of lymphoma in patients with IBD treated with AZA/MP compared with background population.”